Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.
Ozempic and Wegovy contain the same drug, semaglutide, and both are made by Novo Nordisk. What differs is the approval, the top dose and what each one is meant to treat. Ozempic is approved for type 2 diabetes, and Wegovy is approved for weight management, so the real question in Ozempic vs Wegovy is which one fits your prescription, your insurance and your budget.
Is Ozempic the Same as Wegovy?
Same drug, different product. Both labels name semaglutide as the active ingredient and Novo Nordisk as the maker, and both work as a GLP-1 receptor agonist that lowers appetite and slows how fast food leaves the stomach. The Wegovy label says combining it with other semaglutide products or other GLP-1 receptor agonists is not recommended, so you take one or the other.
I am Judy, not a doctor. My own GLP-1 story is in my Ozempic for weight loss story. It is one woman’s account and not medical advice, so below I stay with what the labels and trials say.
What Is the Difference Between Ozempic and Wegovy?
| Ozempic | Wegovy | |
|---|---|---|
| Approved use | Type 2 diabetes, heart event risk in diabetes with heart disease, kidney decline in diabetes with kidney disease | Weight reduction, heart event risk in adults with heart disease and obesity or overweight, and a liver condition called MASH |
| Top dose | 2 mg once a week | 2.4 mg once a week, and 7.2 mg in the Wegovy HD version |
| Forms | Weekly injection, and a daily tablet for type 2 diabetes | Weekly injection and a daily pill |
| Self-pay price listed by the maker, October 2026 | $199 a month for the first two fills of 0.25 and 0.5 mg for new patients, then $349 for 0.25 to 1 mg and $499 for 2 mg | $199 a month for the first two fills of 0.25 and 0.5 mg for new patients, then $349 up to 2.4 mg, and $399 for 7.2 mg |
A doctor can prescribe Ozempic for weight loss as an off-label use, which is legal and common but means the weight claim is not on its label. I cover the numbers behind the prices in how much Ozempic costs.
Ozempic vs Wegovy for Weight Loss: Which Is Better?
Wegovy is the one that was tested and approved for weight loss. In the STEP 1 trial, patients on Wegovy 2.4 mg lost an average of 14.9% of body weight over 68 weeks, compared with 2.4% on placebo. Ozempic was tested in adults with type 2 diabetes, and its label reports average weight losses of about 3 to 6.4 kg depending on the dose and trial.
Do not read those two sets of numbers against each other, because the people and the doses were different. Diabetes makes weight loss harder, and a fairer comparison is Wegovy in diabetes: patients there lost an average of 9.6% on 2.4 mg versus 3.4% on placebo. When Ozempic’s label compared 1 mg with 2 mg in one trial, the 2 mg group lost 6.4 kg and the 1 mg group 5.6 kg, a difference the label calls not statistically significant.
Does a Higher Maximum Dose Make Wegovy Stronger Than Ozempic?
It reaches a higher dose, and dose does matter. Wegovy goes up to 2.4 mg, and the newer 7.2 mg dose averaged an 18.8% loss at 72 weeks compared with 3.9% on placebo and 15.5% on the 2.4 mg dose in that trial. Ozempic stops at 2 mg, so a prescriber who wants a higher dose for weight loss would choose Wegovy.
Do Ozempic and Wegovy Lower Cardiovascular Risk?
Both labels carry a cardiovascular risk indication for a specific group. Ozempic’s covers adults with type 2 diabetes and heart disease, and Wegovy’s covers adults with established heart disease and either obesity or overweight. Your own health and medical history decide which label applies, so check with your doctor before assuming either medication lowers your risk.
How Do Insurance Coverage and Price Differ?
Insurance coverage depends on your plan and on why the drug is prescribed. Ozempic’s approved use is type 2 diabetes, so a diabetes prescription is the case insurers are most set up for, while coverage of Wegovy, or of Ozempic prescribed off-label for weight loss, varies by plan. Call your insurer before the first fill, and use the maker’s self-pay prices in the table above as the fallback if coverage falls through.
How Do the Side Effects Compare?
They are the same kind, mostly digestive, and the labels do not allow a clean head to head. In Wegovy’s weight loss trials, nausea affected 44% of patients versus 16% on placebo, and in Ozempic’s diabetes trials it affected about 16% on 0.5 mg and 20% on 1 mg versus 6% on placebo. Both carry a boxed warning about thyroid C-cell tumors in rodents and warnings about pancreatitis and gallbladder disease.
The patients and doses differ again, so I would not pick on side effect rates alone. The signs to call your prescriber about are in Ozempic side effects.
How Do Mounjaro and Zepbound Compare?
Zepbound and Mounjaro contain tirzepatide from Eli Lilly, which targets both GLP-1 and GIP receptors. In the SURMOUNT-1 trial, patients on 5, 10 and 15 mg lost an average of 15.0%, 19.5% and 20.9% over 72 weeks versus 3.1% on placebo. In SURMOUNT-5, a head to head trial of 751 adults, tirzepatide produced an average 20.2% loss against 13.7% for semaglutide, though it was an open-label study.
Averages hide a lot of individual variation, and some people do better on semaglutide or cannot tolerate tirzepatide. That is a decision for you and your prescriber.
Which Should You Ask Your Prescriber About?
Bring your health history, your current weight, your goal weight, your current medications and your goals. Ask your doctor to explain the medical reason for the choice, how effective the dose is expected to be at each step, and how blood glucose will be monitored if you have diabetes. Among weight loss medications, Ozempic and Wegovy share one active ingredient, while compounded semaglutide is a separate product the FDA does not approve, so confirm which one is being prescribed.
If you want weight management and have no diabetes, ask about Wegovy, since it is the version approved for it. If you have type 2 diabetes, Ozempic may be the natural fit. A telehealth visit is one way to start the conversation, and I explain the steps in how to get GLP-1 online.
The program I use is ShedRX, which offers compounded and brand-name GLP-1 options, including a microdosing product, and I earn a commission if you sign up through that link. GobyMeds is another option, reviewed in my GobyMeds review. Ask any provider whether you will get brand-name or compounded medication, because the FDA says compounded drugs are not FDA approved. Code MTVN25 takes $25 off a first GobyMeds order.
Frequently Asked Questions
Can you take Ozempic and Wegovy together?
No. The Wegovy label says combining it with other semaglutide products or other GLP-1 receptor agonists is not recommended. They are the same drug, so taking both would only double up on it.
Is the Wegovy pill the same as Ozempic?
No. The Wegovy pill is a daily semaglutide tablet approved for weight management and heart event risk reduction in adults, and Ozempic is mainly a weekly injection for diabetes. In the trial of the 25 mg pill, the pill group lost an average of 13.6% at 64 weeks versus 2.4% on placebo.
Why is Wegovy approved for weight loss but Ozempic is not?
Because Wegovy was tested in people with obesity or overweight at a higher dose, and Ozempic was tested in people with type 2 diabetes. Approval follows the trials a company runs and submits to the FDA, so the same drug can carry different indications.
Can you switch from Ozempic to Wegovy?
Your prescriber decides that, and the dose schedule is not the same, since Wegovy starts at 0.25 mg and steps up every four weeks to a 2.4 mg maintenance dose. Do not switch on your own or use leftover pens from a different prescription.
Medical disclaimer: this page shares published data and my own experience, and it is not medical advice. Speak with your prescriber before you start, change or stop any medication, this one included.
Sources: I checked the figures against the Ozempic and Wegovy prescribing information, the STEP 1 trial, the SURMOUNT-1 trial and the SURMOUNT-5 trial.